Related Insights

SVB's 2022 healthtech report reveals strong investment opportunity in mental health

 
Christopher Moniz

Healthcare Trends investments 1H2022 – Insight from experts

 
Jonathan Norris

Life science startup hubs: Advantages of Texas

 
Ben Johnson

First quarter healthcare industry trends worth tracking

 
Jonathan Norris

Healthcare industry sectors: An overview of 2021

 
Jonathan Norris

The Advantage of Oz: Offshore Tax Rebates for LSHC R&D in Australia

 
Anton Xavier and Mike Watson

About the Author

Bill Sideris is a Vice President with SVB’s northeast Medical Device and HealthTech practice, where he provides comprehensive financial products and services as well as flexible lending solutions to clients at every stage of development. Previous to this role, he was part of SVB Securities, performing valuations and advising Healthcare and Life Sciences clients on their M&A strategy. Prior to joining SVB, Bill spent time as an R&D Engineer, developing medical devices for ophthalmic and cardiovascular indications in both Fortune 500 and start-up organizations.

Bill graduated with a Professional Doctorate degree in engineering from the Technical University of Delft and a Master of Science degree in biomedical engineering from the University of Houston.